- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Cytosine arabinoside with G-CSF (filgrastim)
Total 519 results
-
Stanford UniversityCompletedMultiple MyelomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent Squamous Cell Carcinoma... and other conditionsUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLymphoma | Thrombocytopenia | Brain and Central Nervous System Tumors | Drug/Agent Toxicity by Tissue/OrganUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Medical College of WisconsinNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute... and other collaboratorsCompletedSevere Aplastic AnemiaUnited States
-
Masonic Cancer Center, University of MinnesotaCompletedFanconi AnemiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedMyelodysplastic Syndromes | Primary Myelofibrosis | Multiple Myeloma | Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Chronic Myelomonocytic Leukemia | Chronic Myeloid Leukemia | Acute Leukemia in RemissionUnited States
-
Northwestern UniversityTerminated
-
Northwestern UniversityTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Cancer Institute (NCI)Cancer and Leukemia Group BCompletedBreast Cancer | High Risk | Cyclophosphamide | Positive Nodes | DoxorubicinUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedAcute Lymphoblastic Leukemia | Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1United States
-
Stanford UniversityOrca Biosystems, Inc.RecruitingMyelodysplastic Syndromes | Myeloproliferative Disorders | Acute Leukemia | Chronic Myelogenous Leukemia | Allogeneic Hematopoietic Cell Transplantation (HCT) | Advanced Hematologic MalignanciesUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRecurrent Renal Cell Carcinoma | Stage IV Skin Melanoma | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Colorectal Carcinoma | Colorectal... and other conditionsUnited States
-
University of NebraskaNational Cancer Institute (NCI)CompletedLymphoma | NeutropeniaUnited States
-
St. Jude Children's Research HospitalCompletedHodgkin's LymphomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterTerminatedGlioblastoma | GliosarcomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedNeuroblastomaUnited States, Canada, Australia, Puerto Rico, New Zealand, Netherlands
-
Children's Oncology GroupNational Cancer Institute (NCI); Children's Cancer GroupCompletedLymphoma | Cardiac ToxicityUnited States, Australia, Canada
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter SyndromeUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedLung Non-Squamous Non-Small Cell Carcinoma | Stage II Lung Non-Small Cell Cancer AJCC v7 | Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV... and other conditionsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, Canada
-
National Cancer Institute (NCI)CompletedAdult Acute Lymphoblastic Leukemia in RemissionUnited States
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnRecurrent Bladder Cancer | Regional Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage III Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Ureter Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder Cancer | Localized Transitional Cell Cancer... and other conditions
-
National Cancer Institute (NCI)RecruitingPrimary Mediastinal Large B-Cell LymphomaUnited States, Canada, Australia, Puerto Rico
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedFollicular Lymphoma | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | B-Cell Non-Hodgkin Lymphoma | Adult Diffuse Large B-Cell Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingRecurrent Adult Lymphoblastic Lymphoma | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic Leukemia | Refractory Lymphoblastic LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
National Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol Specific | Cardiac ToxicityUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedLymphoma | LeukemiaUnited States
-
City of Hope Medical CenterCompletedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Smoldering Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Cancer Prevention Research Institute of TexasCompletedLymphoma | LeukemiaUnited States
-
M.D. Anderson Cancer CenterCompletedHodgkin's DiseaseUnited States
-
M.D. Anderson Cancer CenterTerminatedLymphoma | Leukemia | Myeloma | Myeloproliferative DiseasesUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedStage III Adult Soft Tissue Sarcoma | Stage I Adult Soft Tissue Sarcoma | Stage II Adult Soft Tissue Sarcoma | Adult Rhabdomyosarcoma | Adult Malignant Mesenchymoma | Alveolar Childhood Rhabdomyosarcoma | Embryonal Childhood Rhabdomyosarcoma | Embryonal-botryoid Childhood Rhabdomyosarcoma | Previously... and other conditionsUnited States
-
M.D. Anderson Cancer CenterCompletedLymphoma | Leukemia | Stem Cell TransplantationUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Hematologic Malignancies | Blood Stem Cell Transplant FailureUnited States
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Completed
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
M.D. Anderson Cancer CenterRecruiting
-
Canadian Cancer Trials GroupRoche Pharma AG; Janssen, LP; Karyopharm Therapeutics IncRecruiting
-
Children's Oncology GroupNational Cancer Institute (NCI); EsPhALL Network/ BFM Study GroupRecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | T Acute Lymphoblastic Leukemia | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia, Finland, New Zealand, Saudi Arabia, Germany, Austria, Belgium, Chile, Czechia, France, Italy, Netherlands, Sweden, Switzerland, Hong Kong, Israel
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Non-Hodgkin LymphomaUnited States